Abstract
We used a link between cancer (859,398 reports) and AIDS (50,050 reports) registries in the United States to study whether nasopharyngeal carcinoma (NPC) was increased in the population with AIDS. There was no indication of a significantly increased risk up to or after the AIDS diagnosis, which argues against progressively failing immunity being important in the development of this malignancy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Melbye, M., Coté, T., West, D. et al. Nasopharyngeal carcinoma: an EBV-associated tumour not significantly influenced by HIV-induced immunosuppression. Br J Cancer 73, 995–997 (1996). https://doi.org/10.1038/bjc.1996.194
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.194
This article is cited by
-
Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries
Cancer Causes & Control (2007)